2 trials
Not to exceed the stated recommended daily usage
Collagen, Hydrolyzed Collagen, Glutathione, Sodium Hyaluronate, Propanediol, Butylene Glycol, 1,2-Hexanediol, Glycerin, Sodium Hyaluronate Crosspolymer, Hydrolyzed Glycosaminoglycans, Hyaluronic Acid, Tripeptide-1 , Pentapeptide-3 , Palmitoyl Tripeptide-5, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7, Palmitoyl Pentapeptide-4 , Palmitoyl Hexapeptide-12 , Nonapeptide-1, Hydrolyzed Hyaluronic Acid , Hexapeptide-9, Dipeptide Diaminobutyroyl Benzylamide Diacetate , Copper Tripeptide-1, Acetyl Hexapeptide-8
The purpose of the present invention is to allow the administration of methylcobalamin in a liposomal encapsulation that facilitates absorption after oral ingestion
If low or low-normal, use higher dose supplementation or injectable b12
If regulators expand one pathway, stakeholders will naturally ask whether similar reasoning should apply to future peptides and other investigational compounds